Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.190
+0.080 (3.79%)
Jan 8, 2026, 4:00 PM EST - Market closed
Microbot Medical Market Cap
Microbot Medical has a market cap or net worth of $147.08 million as of January 8, 2026. Its market cap has increased by 791.37% in one year.
Market Cap
147.08M
Enterprise Value
67.82M
1-Year Change
791.37%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since December 1, 1998, Microbot Medical's market cap has increased from $25.90M to $147.08M, an increase of 467.86%. That is a compound annual growth rate of 6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 141.70M | 5.51% |
| Dec 31, 2025 | 134.30M | 606.84% |
| Dec 31, 2024 | 19.00M | -1.04% |
| Dec 29, 2023 | 19.20M | -19.33% |
| Dec 30, 2022 | 23.80M | -55.35% |
| Dec 31, 2021 | 53.30M | 8.78% |
| Dec 31, 2020 | 49.00M | 11.87% |
| Dec 31, 2019 | 43.80M | 758.82% |
| Dec 31, 2018 | 5.10M | -87.06% |
| Dec 29, 2017 | 39.40M | 258.18% |
| Dec 30, 2016 | 11.00M | -75.72% |
| Dec 31, 2015 | 45.30M | -29.77% |
| Dec 31, 2014 | 64.50M | -4.59% |
| Dec 31, 2013 | 67.60M | 10.82% |
| Dec 31, 2012 | 61.00M | 416.95% |
| Dec 30, 2011 | 11.80M | -91.40% |
| Dec 31, 2010 | 137.20M | -7.98% |
| Dec 31, 2009 | 149.10M | 35.05% |
| Dec 31, 2008 | 110.40M | -8.76% |
| Dec 31, 2007 | 121.00M | -41.32% |
| Dec 29, 2006 | 206.20M | -7.62% |
| Dec 30, 2005 | 223.20M | -2.75% |
| Dec 31, 2004 | 229.50M | 242.54% |
| Dec 31, 2003 | 67.00M | 130.24% |
| Dec 31, 2002 | 29.10M | -64.47% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |